Cochrane · systematic review · CD013461

Behavioural activation therapy for depression in adults with non‐communicable diseases

Uphoff, E, Pires, M, Barbui, C, et al. · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library

Common Mental DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
14
current version
GRADE rated
14
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 11 · 78.6%Moderate 3 · 21.4%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Behavioural activation compared with any comparator for depression in adults with non‐communicable diseases

Population: depression in adults with non‐communicable diseases
14 questions
OutcomeEffectEvidenceStatus / GRADE
Treatment efficacy for depression (short term: 8–9 weeks)
Behavioural activation vs any comparator
RR 1.53 [0.98, 2.38]2 studies · 176 participantsLow
Downgraded: risk of bias, imprecision
Treatment efficacy for depression (medium term: 12 months)
Behavioural activation vs any comparator
RR 1.76 [1.01, 3.08]1 study · 92 participantsModerate
Downgraded: imprecision, inconsistency
Treatment efficacy for depression (long term: 24 months)
Behavioural activation vs any comparator
RR 1.42 [0.91, 2.23]1 study · 67 participantsModerate
Downgraded: imprecision, inconsistency
Treatment acceptability (short term: 2 months)
Behavioural activation vs any comparator
RR 1.81 [0.68, 4.82]1 study · 80 participantsLow
Downgraded: risk of bias, imprecision
Treatment acceptability (medium term: 12 months)
Behavioural activation vs any comparator
RR 0.88 [0.25, 3.1]1 study · 101 participantsLow
Downgraded: risk of bias, imprecision
Improvement in depression symptoms (short term: 5–6 months)
Behavioural activation vs any comparator
no estimate extracted2 studies · 176 participantsLow
Downgraded: risk of bias, imprecision
Improvement in depression symptoms (medium term: 12 months)
Behavioural activation vs any comparator
no estimate extracted2 studies · 172 participantsLow
Downgraded: risk of bias, imprecision
Improvement in depression symptoms (long term: 5 months)
Behavioural activation vs any comparator
no estimate extracted1 study · 67 participantsModerate
Downgraded: imprecision, inconsistency
Quality of life (short term: 6 months)
Behavioural activation vs any comparator
no estimate extracted1 study · 80 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Quality of life (medium term: 12 months)
Behavioural activation vs any comparator
no estimate extracted1 study · 80 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Social adjustment and functioning (short term: 6 months)
Behavioural activation vs any comparator
no estimate extracted1 study · 80 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Social adjustment and functioning (medium term: 12 months)
Behavioural activation vs any comparator
no estimate extracted1 study · 80 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Improvement in anxiety symptoms (short term: 6 months)
Behavioural activation vs any comparator
no estimate extracted1 study · 80 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Improvement in anxiety symptoms (medium term: 12 months)
Behavioural activation vs any comparator
no estimate extracted1 study · 80 participantsLow
Downgraded: risk of bias, imprecision, inconsistency